The Federal Ministry of Commerce and Industry, through the Directorate General of Commerce and Trade Remedies (DGTR), has launched an anti-dumping investigation into the import of vitamin A palmitate.
The investigation stems from a petition filed by Piramal Pharma Limited (PPL) and covers imports from China, the European Union (EU) and Switzerland.
The DGTR, under the Union Ministry of Commerce and Industry, officially suspended a wide-ranging anti-dumping investigation into imports of vitamin A palmitate from China, the EU and Switzerland in February 2024.
Vitamin A palmitate is a common vitamin supplement and is available in both oral and injectable forms for the treatment of vitamin A deficiency. Vitamin A palmitate encompasses a variety of strengths and forms, except those specifically designated for animal consumption, and has been identified as a product under consideration (PUC).
The applicant alleges that the domestic industry is being harmed by dumped imports of covered goods originating from or exported from the covered countries, and the applicant claims that anti-dumping duties on imports of covered goods originating from or exported from the covered countries are being imposed. is asking for the imposition of Target country.
The petitioner submitted that PUC is used in a wide range of intermediate products falling under various sectors including food, cosmetics and pharmaceutical industries. The affected goods are generally imported into India under tariff entry 29362100 of Schedule I of the Act. However, PUC is imported under tariff items 29362290, 29362800, 29369000, 29362690, and 29362990 of Schedule I of the Act.
According to the Commerce Department’s notice, parties to the investigation will have 15 days from the start of the investigation to submit comments on the PUC.
According to PPL, the sole producer of affected products in India, there is no significant difference between domestically produced products and imported products from affected countries. This argument classifies them as “similar products” and asserts the need for anti-dumping measures.
Efforts to obtain reliable pricing information for the products in question from the EU and Switzerland proved futile, and estimates based on production costs were proposed. Export prices have been calculated and the dumping margin has been shown to be above the minimum level, further strengthening the case for the investigation.
Evidence presented by PPL suggests that domestic industry performance is declining due to increased imports, lower prices and restraints.
In light of these allegations and prima facie evidence, the authorities have launched an investigation to determine the existence, extent and impact of the alleged dumping, with a view to recommending appropriate anti-dumping measures to protect the domestic industry.
